Janney Montgomery Scott’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-11,550
Closed -$217K 2079
2018
Q3
$217K Sell
11,550
-3,650
-24% -$72.7K ﹤0.01% 1883
2018
Q2
$292K Sell
15,200
-900
-6% -$18.2K ﹤0.01% 1665
2018
Q1
$344K Hold
16,100
﹤0.01% 1535
2017
Q4
$331K Buy
16,100
+1,599
+11% +$29.7K ﹤0.01% 1533
2017
Q3
$267K Buy
14,501
+283
+2% +$6.23K ﹤0.01% 1561
2017
Q2
$355K Buy
14,218
+1,767
+14% +$37.1K ﹤0.01% 1356
2017
Q1
$250K Sell
12,451
-467
-4% -$10.3K ﹤0.01% 1509
2016
Q4
$319K Sell
12,918
-1,033
-7% -$23.2K ﹤0.01% 1295
2016
Q3
$277K Sell
13,951
-28,251
-67% -$524K ﹤0.01% 1225
2016
Q2
$580K Buy
42,202
+20,101
+91% +$279K 0.01% 495
2016
Q1
$304K Sell
22,101
-500
-2% -$5.73K 0.01% 960
2015
Q4
$229K Sell
22,601
-500
-2% -$5.45K 0.01% 1163
2015
Q3
$232K Buy
23,101
+1,500
+7% +$17.5K 0.01% 1176
2015
Q2
$320K Buy
21,601
+6,500
+43% +$101K 0.01% 1461
2015
Q1
$251K Buy
15,101
+500
+3% +$7.8K ﹤0.01% 1907
2014
Q4
$221K Buy
+14,601
New +$212K ﹤0.01% 1930

Other funds holding PMD

Janney Montgomery Scott's PMD Position: Q4 2018 in Review

Janney Montgomery Scott sold out of Psychemedics Corporation (PMD) in Q4 2018, closing a stake of 11,550 shares — an estimated $217K sold.

Janney Montgomery Scott first reported a position in PMD in Q4 2014 and held it in 16 quarters. The position peaked at $580K in Q2 2016. 54 funds tracked by Wall St. Rank hold PMD as of Q4 2018.

  • Janney Montgomery Scott reported no remaining Psychemedics Corporation position as of Q4 2018 after selling out during the quarter.
  • Janney Montgomery Scott sold 11,550 Psychemedics Corporation shares in Q4 2018, an estimated $217K.
  • Janney Montgomery Scott first reported a position in Psychemedics Corporation in Q4 2014 and held it in 16 quarters.
  • Janney Montgomery Scott's Psychemedics Corporation position peaked at $580K in Q2 2016.
  • 54 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2018.

Based on Janney Montgomery Scott's 13F filing for Q4 2018, filed 1 Feb 2019.